By sharing this content, you are consenting to share your data to this social media provider. More information are available in our Privacy Statement.
Cookie Disclaimer
We use cookies so that we can offer you the best possible website experience. This includes cookies which are necessary for the operation of the app and the website, as well as other cookies which are used solely for anonymous statistical purposes, for more comfortable website settings, or for the display of personalized content. You are free to decide in the Cookie Settings which categories you would like to permit. Please note that depending on what you select, the full functionality of the website may no longer be available. You may review and change your choices at any time. Further information can be found in our Privacy Statement.
Cookie Disclaimer
These cookies are necessary for the website to operate. Our website cannot function without these cookies and they can only be disabled by changing your browser preferences.
These cookies enable the provision of advanced functionalities and are used for personalization. The cookies are set in particular in response to your actions and depend on your specific service requests (e.g., setting the language).
These cookies may be set to learn more about your interests and show you relevant ads on other websites. These cookies work by uniquely identifying your browser and device. By integrating these cookies, we aim to learn more about your interests and your surfing behavior and to be able to place our advertising in a targeted manner.
{"analytics":"targeting","share":"targeting"}
Disclaimer
Publication of Merck KGaA, Darmstadt, Germany.
In the United States and Canada the subsidiaries of
Merck KGaA, Darmstadt, Germany operate under the umbrella brand EMD.
High transparency and mutual trust are the key elements for the cooperation with our investors. We offer the opportunity for investors to ask specific questions regarding the role and composition of the supervisory board in corresponding meetings. To limit the number of inquiries to a feasible amount, we will be concentrating on investors who hold >2% of free floating shares of Merck KGaA, Darmstadt, Germany. Furthermore, we encourage all investors and shareholders to direct their questions to the Investor Relations Team at Merck KGaA, Darmstadt, Germany.
To provide the opportunity to be informed about the content of meetings between the supervisory board and investors, we offer the possibility to download the transcripts.
Date
Topic
Participants
Transcript
04.03.2017
Role of the board in the specific context at Merck KGaA, Darmstadt, Germany